SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
TheMaven, Inc. (MVEN) trades at a trailing P/E of 0.7. Trailing earnings yield is 142.86%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.7); earnings yield beats bond yields (142.86%).
- Trailing Earnings Yield 142.86% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 71/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MVEN
Valuation Multiples
P/E (TTM)0.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.60
Book Value / Share$0.00
Revenue / Share$2.83
FCF / Share$0.00
Yields & Fair Value
Earnings Yield142.86%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.59 |
$0.00 |
$-236K |
- |
| 2015 |
$-0.47 |
$0.00 |
$-197K |
- |
| 2016 |
$-1.73 |
$0.00 |
$-2.19M |
- |
| 2017 |
$-9.27 |
$77K |
$-6.28M |
-8161.6% |
| 2018 |
$-21.95 |
$5.7M |
$-26.07M |
-457.3% |
| 2019 |
$-0.02 |
$53.34K |
$-38.5K |
-72.2% |
| 2020 |
$-42.69 |
$128.03M |
$-89.23M |
-69.7% |
| 2021 |
$-43.03 |
$189.14M |
$-89.94M |
-47.6% |
| 2024 |
$-2.85 |
$125.91M |
$-100.71M |
-80% |
| 2025 |
$0.60 |
$134.83M |
$124.86M |
92.6% |
